Tradestie Institutional Equity Comparison Engine
JAGX vs PTN โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
PTN Overall Edge
PTN Captures Institutional Edge (3โ0 Pillars ยท 6โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Palatin Technologies, Inc. (PTN) driven by superior Valuation, Growth & Margin, Momentum & Technical. Fundamentally, JAGX trades at N/M Forward P/E with -90.2% operating margin (-58.9% YoY revenue) versus PTN at 42.9x Forward P/E and -65.7% operating margin (-80.1% YoY). In options structure, JAGX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against PTN sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
PTN
JAGX N/M vs PTN 42.9x Fwd P/E
Growth & Margin Winner
PTN
Op Margin -90.2% vs -65.7% ยท YoY -58.9% vs -80.1%
Momentum & Technical Winner
PTN
1Y -77.3% vs -43.3% ยท 52W Pos 0% vs 6%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
JAGX
NASDAQ
Jaguar Health, Inc.
Pharmaceutical Preparations
$0.39
-7.74% 1D
Market Cap
$5.6M
1M Return
-89.04%
1Y Return
-77.27%
Forward P/E
N/M
Unified AI Score
54.5 / 100
HOLD
Tech 60.0
Fund 57.0
Flow 50.0
Mom 60.0
PTN
US Equity
Palatin Technologies, Inc.
Pharmaceutical Preparations
$6.12
-1.69% 1D
Market Cap
$11.1M
1M Return
+1.74%
1Y Return
-43.29%
Forward P/E
42.9x
Unified AI Score
31.5 / 100
SELL
Tech 15.0
Fund 30.0
Flow 50.0
Mom 40.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
JAGX -77.27%
PTN -43.29%
Spread: +33.98 pp (PTN Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | JAGX Revenue | PTN Revenue | JAGX Op. Margin | PTN Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | $10M | $60M | -501.3% | 59.3% | PTN |
| FY2020 | $10M | $0M | -283.9% | -20007.6% | JAGX |
| FY2021 | $0M | N/A | -939.1% | N/A | JAGX |
| FY2022 | $10M | $0M | -287.8% | -2491.6% | JAGX |
| FY2023 | $10M | $0M | -351.3% | -668.7% | JAGX |
| FY2024 | $10M | $0M | -263.8% | -501.0% | JAGX |
| FY2025 | $10M | N/A | -398.8% | N/A | JAGX |
| FY2026 | N/A | $10M | N/A | -65.7% | PTN |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | JAGX | PTN | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $5.6M | $11.1M | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | 42.9x | Lower Multiple | PTN |
| Forward P/E Ratio Valuation | N/M | 42.9x | Lower Multiple | PTN |
| Revenue Growth (YoY) Growth | -58.9% | -80.1% | Higher Growth | JAGX |
| Operating Margin (TTM) Profitability | -90.2% | -65.7% | Higher Margin | PTN |
| Net Profit Margin Profitability | -130.8% | -63.5% | Higher Margin | PTN |
| Return on Equity (ROE) Capital Efficiency | -548.8% | -877.5% | Higher ROE | JAGX |
| 52-Week Range Position Momentum | 0% ($0โ$42) | 6% ($5โ$31) | Stronger Trend | PTN |
| Beta / 30D Volatility Risk Regime | 30.19ฮฒ ยท 228% Vol | 0.87ฮฒ ยท 106% Vol | Lower Realized Risk | PTN |
| Unified Institutional Score Composite Signal | 54.5 / 100 (HOLD) | 31.5 / 100 (SELL) | Higher Composite | JAGX |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full JAGX vs PTN Buy Guide
JAGX
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
PTN
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither JAGX nor PTN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.